carmustine has been researched along with Spinal Cord Neoplasms in 5 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Spinal Cord Neoplasms: Benign and malignant neoplasms which occur within the substance of the spinal cord (intramedullary neoplasms) or in the space between the dura and spinal cord (intradural extramedullary neoplasms). The majority of intramedullary spinal tumors are primary CNS neoplasms including ASTROCYTOMA; EPENDYMOMA; and LIPOMA. Intramedullary neoplasms are often associated with SYRINGOMYELIA. The most frequent histologic types of intradural-extramedullary tumors are MENINGIOMA and NEUROFIBROMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Between April 1986 and March 1989, ten patients under 21 years of age with histologically confirmed malignant astrocytoma, received marrow-ablative chemotherapy with either thiotepa and Etoposide (five patients) or thiotepa, Etoposide and BCNU (five patients), followed by bone marrow 'rescue'." | 5.06 | High-dose multi-agent chemotherapy followed by bone marrow 'rescue' for malignant astrocytomas of childhood and adolescence. ( August, C; Bayever, E; Finlay, JL; Freid, A; Kamani, N; Kramer, E; Packer, R; Rorke, L; Sutton, L; Zimmerman, R, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Debiais, S | 1 |
| Bonnaud, I | 1 |
| Cottier, JP | 1 |
| Destrieux, C | 1 |
| Saudeau, D | 1 |
| de Toffol, B | 1 |
| Arbion, F | 1 |
| Benboubker, L | 1 |
| Autret, A | 1 |
| Godard, J | 1 |
| Viennet, G | 1 |
| Raul, JS | 1 |
| Plouvier, E | 1 |
| Miny, J | 1 |
| Jacquet, G | 1 |
| Czorny, A | 1 |
| Finlay, JL | 1 |
| August, C | 1 |
| Packer, R | 1 |
| Zimmerman, R | 1 |
| Sutton, L | 1 |
| Freid, A | 1 |
| Rorke, L | 1 |
| Bayever, E | 1 |
| Kamani, N | 1 |
| Kramer, E | 1 |
| Heros, DO | 1 |
| Renkens, K | 1 |
| Kasdon, DL | 1 |
| Adelman, LS | 1 |
| Medoff, G | 1 |
| Valeriote, F | 1 |
| Lynch, RG | 1 |
| Schlessinger, D | 1 |
| Kobayashi, GS | 1 |
1 trial available for carmustine and Spinal Cord Neoplasms
| Article | Year |
|---|---|
High-dose multi-agent chemotherapy followed by bone marrow 'rescue' for malignant astrocytomas of childhood and adolescence.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bone Marrow Transplantation | 1990 |
4 other studies available for carmustine and Spinal Cord Neoplasms
| Article | Year |
|---|---|
A spinal cord intravascular lymphomatosis with exceptionally good outcome.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capillaries; Carmustine; Central Nervous Syste | 2004 |
[Intramedullary spread of a cerebral oligodendroglioma. Two case reports].
Topics: Abducens Nerve Diseases; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Pro | 2000 |
Patterns of recurrence in glioma patients after interstitial irradiation and chemotherapy: report of three cases.
Topics: Adult; Brachytherapy; Brain Neoplasms; Carmustine; Combined Modality Therapy; Female; Glioma; Humans | 1988 |
Synergistic effect of amphotericin B and 1,3-bis(2-chloroethyl)-1-nitrosourea against a transplantable AKR leukemia.
Topics: Amphotericin B; Animals; Bone Marrow Cells; Brain Neoplasms; Carmustine; Cell Survival; Clone Cells; | 1974 |